Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
NeuroPace Inc
13G/A
Amendment 1
NPCE · 641288105
|
12.3% |
9/4/2026
Event 8/31/2026
|
|||
| First Light Asset Management, LLC | 11.8% | ||||
| Mathew P. Arens | 12.3% | ||||
|
Neogenomics, Inc.
13G/A
Amendment 2
NEO · 64049M209
|
8.4% |
8/14/2026
Event 6/30/2026
|
|||
| First Light Asset Management, LLC | 8.0% | ||||
| Mathew P. Arens | 8.4% | ||||
|
Axogen, Inc.
13G/A
Amendment 4
AXGN · 05463X106
|
7.6% |
8/14/2026
Event 6/30/2026
|
|||
| First Light Asset Management, LLC | 7.0% | ||||
| Mathew P. Arens | 7.6% | ||||
|
Palvella Therapeutics, Inc.
13G/A
Amendment 1
PVLA · 697947109
|
5.3% |
8/14/2026
Event 6/30/2026
|
|||
| First Light Asset Management, LLC | 5.3% | ||||
| Mathew P. Arens | 5.3% | ||||
|
TriSalus Life Sciences, Inc.
13G/A
Amendment 1
TLSI · 89680M101
|
10.7% |
7/7/2026
Event 6/30/2026
|
|||
| First Light Asset Management, LLC | 10.7% | ||||
| Mathew P. Arens | 10.7% | ||||
|
TriSalus Life Sciences, Inc.
13G
TLSI · 89680M101
|
8.8% |
5/15/2026
Event 3/31/2026
|
|||
| First Light Asset Management, LLC | 8.8% | ||||
| Mathew P. Arens | 8.8% | ||||
|
NeuroPace, Inc.
13G
NPCE · 641288105
|
8.7% |
5/15/2026
Event 3/31/2026
|
|||
| First Light Asset Management, LLC | 8.4% | ||||
| Mathew P. Arens | 8.7% | ||||
|
Neogenomics, Inc.
13G/A
Amendment 1
NEO · 64049M209
|
10.8% |
5/7/2026
Event 4/30/2026
|
|||
| First Light Asset Management, LLC | 10.5% | ||||
| Mathew P. Arens | 10.8% | ||||
|
Axogen, Inc.
13G/A
Amendment 3
AXGN · 05463X106
|
6.8% |
5/7/2026
Event 4/30/2026
|
|||
| First Light Asset Management, LLC | 6.2% | ||||
| Mathew P. Arens | 6.8% | ||||
|
SI-BONE, Inc.
13G/A
Amendment 1
SIBN · 825704109
|
18.4% |
5/7/2026
Event 4/30/2026
|
|||
| First Light Asset Management, LLC | 18.0% | ||||
| Mathew P. Arens | 18.4% | ||||
|
Health Catalyst, Inc.
13D/A
Amendment 1
HCAT · 42225T107
|
18.3% |
3/13/2026
Event 3/12/2026
|
|||
| First Light Asset Management, LLC | 17.5% | ||||
| Mathew P. Arens | 18.3% | ||||
|
908 Devices Inc.
13G/A
Amendment 2
MASS · 65443P102
|
17.1% |
2/17/2026
Event 12/31/2025
|
|||
| First Light Asset Management, LLC | 16.5% | ||||
| Mathew P. Arens | 17.1% | ||||
|
Palvella Therapeutics, Inc.
13G
PVLA · 697947109
|
7.5% |
2/17/2026
Event 12/31/2025
|
|||
| First Light Asset Management, LLC | 7.5% | ||||
| Mathew P. Arens | 7.5% | ||||
|
Organogenesis Holdings Inc.
13G/A
Amendment 1
ORGO · 68621F102
|
3.1% |
2/17/2026
Event 12/31/2025
|
|||
| First Light Asset Management, LLC | 2.9% | ||||
| Mathew P. Arens | 3.1% | ||||
|
KORU Medical Systems, Inc.
13G/A
Amendment 10
KRMD · 759910102
|
8.3% |
2/17/2026
Event 12/31/2025
|
|||
| First Light Asset Management, LLC | 8.0% | ||||
| Mathew P. Arens | 8.3% | ||||
|
Simulations Plus, Inc.
13G
SLP · 829214105
|
13.2% |
2/6/2026
Event 1/31/2026
|
|||
| First Light Asset Management, LLC | 13.2% | ||||
| Mathew P. Arens | 13.2% | ||||
|
SI-BONE, Inc.
13G
SIBN · 825704109
|
11.9% |
12/5/2025
Event 11/30/2025
|
|||
| First Light Asset Management, LLC | 11.6% | ||||
| Mathew P. Arens | 11.9% | ||||
|
908 Devices Inc.
13G/A
Amendment 1
MASS · 65443P102
|
12.9% |
12/5/2025
Event 11/30/2025
|
|||
| First Light Asset Management, LLC | 12.9% | ||||
| Mathew P. Arens | 12.9% | ||||
|
Health Catalyst, Inc.
13D
HCAT · 42225T107
|
19.7% |
12/3/2025
Event 12/1/2025
|
|||
| First Light Asset Management, LLC | 18.9% | ||||
| Mathew P. Arens | 19.7% | ||||
|
Health Catalyst, Inc.
13G/A
Amendment 3
HCAT · 42225T107
|
19.8% |
11/14/2025
Event 9/30/2025
|
|||
| First Light Asset Management, LLC | 18.9% | ||||
| Mathew P. Arens | 19.8% | ||||
|
AnaptysBio Inc.
13G/A
Amendment 2
ANAB · 032724106
|
3.1% |
11/14/2025
Event 9/30/2025
|
|||
| First Light Asset Management, LLC | 2.8% | ||||
| Mathew P. Arens | 3.1% | ||||
|
908 Devices Inc.
13G
MASS · 65443P102
|
9.8% |
11/14/2025
Event 9/30/2025
|
|||
| First Light Asset Management, LLC | 9.8% | ||||
| Mathew P. Arens | 9.8% | ||||
|
Axogen, Inc.
13G/A
Amendment 2
AXGN · 05463X106
|
12.9% |
11/14/2025
Event 9/30/2025
|
|||
| First Light Asset Management, LLC | 12.2% | ||||
| Mathew P. Arens | 12.9% | ||||
|
Performant Healthcare, Inc.
13G/A
Amendment 4
PHLT · 71377E105
|
16.4% |
8/14/2025
Event 6/30/2025
|
|||
| First Light Asset Management, LLC | 15.4% | ||||
| Mathew P. Arens | 16.4% | ||||
|
Neogenomics, Inc.
13G
NEO · 64049M209
|
7.6% |
8/14/2025
Event 6/30/2025
|
|||
| First Light Asset Management, LLC | 7.4% | ||||
| Mathew P. Arens | 7.6% | ||||
|
Organogenesis Holdings, Inc.
13G
ORGO · 68621F102
|
6.6% |
8/14/2025
Event 6/30/2025
|
|||
| First Light Asset Management, LLC | 6.4% | ||||
| Mathew P. Arens | 6.6% | ||||
|
Anaptysbio, Inc
13G/A
Amendment 1
ANAB · 032724106
|
7.7% |
8/7/2025
Event 7/31/2025
|
|||
| First Light Asset Management, LLC | 7.3% | ||||
| Mathew P. Arens | 7.7% | ||||
|
Health Catalyst, Inc.
13G/A
Amendment 2
HCAT · 42225T107
|
17.2% |
5/13/2025
Event 5/7/2025
|
|||
| First Light Asset Management, LLC | 17.0% | ||||
| Mathew P. Arens | 17.2% | ||||
|
KORU Medical Systems, Inc.
13G/A
Amendment 9
KRMD · 759910102
|
10.5% |
5/7/2025
Event 4/30/2025
|
|||
| First Light Asset Management, LLC | 10.2% | ||||
| Mathew P. Arens | 10.5% | ||||
|
Paragon 28, Inc.
13G/A
Amendment 2
FNA · 69913P105
|
1.7% |
3/7/2025
Event 2/28/2025
|
|||
| First Light Asset Management, LLC | 1.2% | ||||
| Mathew P. Arens | 1.7% | ||||
|
AnaptysBio Inc.
13G
ANAB · 032724106
|
15.2% |
3/7/2025
Event 2/28/2025
|
|||
| First Light Asset Management, LLC | 15.2% | ||||
| Mathew P. Arens | 15.2% | ||||
|
KORU Medical Systems, Inc.
13G/A
Amendment 8
KRMD · 759910102
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| First Light Asset Management, LLC | 9.7% | ||||
| Mathew P. Arens | 10.0% | ||||
|
Health Catalyst, Inc.
13G/A
Amendment 1
HCAT · 42225T107
|
11.8% |
2/7/2025
Event 12/31/2024
|
|||
| First Light Asset Management, LLC | 11.8% | ||||
| Mathew P. Arens | 11.8% | ||||
|
Paragon 28, Inc.
13G/A
Amendment 1
FNA · 69913P105
|
12.7% |
1/29/2025
Event 12/31/2024
|
|||
| First Light Asset Management, LLC | 12.1% | ||||
| Mathew P. Arens | 12.7% | ||||
|
OptimizeRx Corporation
13G/A
Amendment 2
OPRX · 68401U204
|
0% |
1/8/2025
Event 12/31/2024
|
|||
| First Light Asset Management, LLC | 0% | ||||
| Mathew P. Arens | 0% | ||||
|
Axogen, Inc.
13G/A
Amendment 1
AXGN · 05463X106
|
10.5% |
1/8/2025
Event 12/31/2024
|
|||
| First Light Asset Management, LLC | 10.5% | ||||
| Mathew P. Arens | 10.5% | ||||